Clinical Trial Update: Abnormal Glucose Tolerance in Allogeneic Hematopoietic Stem Cell Transplantation

View source ↗

Summary

A clinical trial update from Ruijin Hospital studying abnormal glucose tolerance in patients undergoing allogeneic hematopoietic stem cell transplantation. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Impaired Fasting Glucose

Snippet

Sponsor: Ruijin Hospital | Conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, Diabetes Mellitus | Status: NOT_YET_RECRUITING